Our results demonstrated knockdown of Hsp90 suppressed HER2 expression, p-AKT activation and PD-L1 expression, leading to the inhibited cervical cancer cell proliferation and migration in vitro and tumor progression in vivo. The gene discussed is ERBB2; the disease is cervical carcinoma.